The purpose of the study is to assess the success of a single administration of Staccato alprazolam compared with placebo both in rapidly terminating a seizure episode within 90 seconds and with no recurrence of seizure(s) up to 2 hours after investigational medicinal product (IMP) administration.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Treatment success for the treated seizure within 90 seconds after investigational medicinal product (IMP) administration
Timeframe: From start of IMP treatment through 6 hours
Treatment success for the treated seizure with no recurrence up to 2 hours
Timeframe: From start of IMP treatment through 2 hours